## Pathophysiological Mechanism of Thrombosis in Atrial Fibrillation ### Clinical Context This patient has atrial fibrillation (AF) with an acute ischemic stroke—a classic thromboembolic complication. The mechanism is NOT local thrombosis in the cerebral vessel but rather **cardioembolic stroke** originating from the heart. ### Virchow's Triad in AF-Related Thrombosis | Component | Mechanism in AF | |-----------|----------------| | **Blood Stasis** | Loss of atrial contraction → blood pooling in LAA → reduced flow velocity | | **Endothelial Injury** | Atrial wall stretch and inflammation from AF → endothelial dysfunction | | **Blood Composition** | Hypercoagulability from inflammation and tissue factor release | ### Why Blood Stasis in LAA is the PRIMARY Mechanism **Key Point:** In atrial fibrillation, the irregular rhythm abolishes effective atrial contraction, causing blood to pool and stagnate in the **left atrial appendage (LAA)**—the most common site of thrombus formation in AF. 1. **Reduced flow velocity** in the LAA (< 20 cm/s) → platelet aggregation and fibrin deposition 2. **Thrombus formation** occurs over days to weeks 3. **Embolization** occurs when the clot dislodges and travels via the aorta to cerebral vessels ### High-Yield Fact **High-Yield:** The LAA is the source of thrombi in ~90% of cardioembolic strokes in AF patients. This is why LAA occlusion devices (Watchman) are used as alternatives to anticoagulation in AF. ### Clinical Pearl **Clinical Pearl:** The patient's 2-year history of untreated AF is the critical risk factor. Even paroxysmal AF carries significant stroke risk (CHA₂DS₂-VASc score determines anticoagulation need). 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.